Patent-family-84568960

Patent Number: EP-4389865-A1

Publication Year: 2024

Application Year: 2022

Priority Year: 2022

Jurisdictions: EP

Status: Pending

Inventors:

HOFF TINE HOFF TINE JOERGENSEN CHRISTIAN JOERGENSEN CHRISTIAN ISAK SALOMON JESPER SALOMON JESPER KRISTENSEN KARINA KRISTENSEN KARINA SANDGAARD REISER ANNA REISER ANNA VERENA

Applicants:

  1. Novo Nordisk (Denmark)
    2. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]
  2. Novozymes (Denmark)
    3. [NORA names: Novonesis; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention relates to compositions suitable for cell detachment comprising polypeptides with protease activity. The present invention further relates to polypeptides with protease activity, polynucleotides encoding said polypeptides, nucleic acid constructs and expression vectors comprising said polynucleotides, recombinant host cells comprising said nucleic acid constructs or expressions vectors, methods of producing said polypeptides, granules comprising said polypeptides, fermentation broth formulations comprising said polypeptides, and methods and uses employing said polypeptides.

Patent Family Records (2)

RECOMBINANT PROTEASE FOR CELL DETACHMENT  

NOVO NORDISK PHARMATECH AS, NOVOZYMES AS, Novo Nordisk (Denmark), Novozymes (Denmark) HOFF TINE, JOERGENSEN CHRISTIAN, SALOMON JESPER, (...more)

2024, WO-2024133500-A1

RECOMBINANT PROTEASE FOR CELL DETACHMENT

Novo Nordisk (Denmark), Novo Nordisk Pharmatech AS, Novozymes (Denmark), Novozymes AS HOFF TINE, JOERGENSEN CHRISTIAN ISAK, SALOMON JESPER, (...more)

2024, EP-4389865-A1

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: 33external link

References to Publications: 3external link